1. Siegel, R, Naishadham, D, Jemal, A. Cancer statistics. CA Cancer J Clin 2012; 62(1):10–29.
Google Scholar | Crossref | Medline | ISI2. Bray, F . Transitions in human development and the global cancer burden. World Cancer Rep 2014; 34, doi:10.1596/978-1-4648-0349-9_ch3.
Google Scholar | Crossref3. Molina, JR, Yang, P, Cassivi, SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584–594.
Google Scholar | Crossref | Medline | ISI4. Qi, L, Li, Y, Qin, Y, et al. An individualized signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy. Br J Cancer 2016; 115(12): 1513–1519.
Google Scholar | Crossref | Medline5. Lv, H, Han, T, Shi, X, et al. Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in non-small cell lung cancer. Med Oncol 2014; 31(8): 86.
Google Scholar | Crossref | Medline6. Sparreboom, A, Verweij, J. Advances in cancer therapeutics. Clin Pharmacol Ther. 2009; 85:113–117.
Google Scholar | Crossref | Medline7. De Luca, A, Pellizzari Tregno, F, Sau, A, et al. Glutathione S‐transferase P 1‐1 as a target for mesothelioma treatment. Cancer Sci. 2013; 104(2): 223–230.
Google Scholar | Crossref | Medline8. Goričar, K, Kovač, V, Jazbec, J, et al. Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma. Cancer Epidemiol 2015; 39: 182–188.
Google Scholar | Crossref | Medline9. Yuan, ZJ, Zhou, WW, Liu, W, et al. Association of GSTP1 and RRM1 polymorphisms with the response and toxicity of gemcitabine-cisplatin combination chemotherapy in Chinese patients with non-small cell lung cancer. Asian Pac J Cancer Prev 2015; 16(10): 4347–4351.
Google Scholar | Crossref | Medline10. Booten, R, Ward, T, Heighway, J, et al. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer. J Thorac Oncol 2006; 1(7): 679–683.
Google Scholar | Medline11. Ada, AO, Kunak, SC, Hancer, F, et al. CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients. Neoplasma 2010; 57(6): 512.
Google Scholar | Crossref | Medline12. Yang, Y, Xian, L. The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis. Tumor Biol 2014; 35: 6791–6799.
Google Scholar | Crossref | Medline13. Ibarrola-Villava, M, Martin-Gonzalez, M, Lazaro, P, et al. Role of glutathione S‐transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism. Br J Dermatol 2012; 166(6): 1176–1183.
Google Scholar | Crossref | Medline14. Wheeler, HE, Gamazon, ER, Stark, AL, et al. Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations. The Pharmacogenom J. 2013; 13(1): 35–43.
Google Scholar | Crossref | Medline15. Han, ZG, Tao, J, Yu, TT, et al. Effect of GSTP1 and ABCC2 polymorphisms on treatment response in patients with advanced non-small cell lung cancer undergoing platinum-based chemotherapy: a study in a Chinese Uygur population. Med Sci Monit 2017;23: 1999–2006.
Google Scholar | Crossref | Medline16. Tiseo, M, Bordi, P, Bortesi, B, et al. ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. Br J Cancer 2013; 108(8): 1695–1703.
Google Scholar | Crossref | Medline17. Liu, K, Lin, Q, Ding, H, et al. Predictive potential role of GSTs gene polymorphisms in the treatment outcome of advanced non-small cell lung cancer patients. Int J Clin Exp Med 2015; 8: 20918–20924.
Google Scholar | Medline18. Deng, JH, Deng, J, Shi, DH, et al. Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients. Clin Transl Oncol 2015; 17(9): 720–726.
Google Scholar | Crossref | Medline19. Jia, W, Sun, JY, Jia, KY, et al. Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer. Genet Mol Res 2016; 15(3), doi:10.4238/gmr.15037668.
Google Scholar | Crossref20. Zhou, F, Yu, Z, Jiang, T, et al. Genetic polymorphisms of GSTP1 and XRCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients. Swiss Med Wkly 2011; 141: w13275.
Google Scholar | Medline21. Ke, HG, Li, J, Shen, Y, et al. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. Asian Pac J Cancer Prev 2012; 13(9): 4413–4416.
Google Scholar | Crossref | Medline22. Han, B, Guo, Z, Ma, Y, et al. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy. Int J Clin Exp Pathol 2015; 8(4): 4113.
Google Scholar | Medline | ISI23. Lu, C, Spitz, MR, Zhao, H, et al. Association between glutathione S‐transferase π polymorphisms and survival in patients with advanced non-small cell lung carcinoma. Cancer Interdiscip Int J Am Cancer Soc 2006; 106(2): 441–447.
Google Scholar24. Bu, L, Zhang, LB, Mao, X, et al. GSTP1 IIe105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer. Genet Mol Res 2016; 15(2), doi:10.4238/gmr.15027611.
Google Scholar | Crossref | Medline25. Chen, JB, Wang, F, Wu, JJ, et al. Glutathione S-transferase pi polymorphism contributes to the treatment outcomes of advanced non-small cell lung cancer patients in a Chinese population. Genet Mol Res 2016; 15(3), doi:10.4238/gmr.15037498.
Google Scholar | Crossref26. Zhao, R, Chen, G. Role of GSTP1 IIe105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer. Int J Clin Exp Pathol 2015; 8: 14909–14916.
Google Scholar | Medline27. Vlachogeorgos, GS, Manali, ED, Blana, E, et al. Placental isoform glutathione S‐transferase and P‐glycoprotein expression in advanced non-small cell lung cancer: Association with response to treatment and survival. Cancer Cytopathology: Interdiscip Int J Am Cancer Soc 2008; 114(6): 519–526.
Google Scholar28. Kalikaki, A, Kanaki, M, Vassalou, H, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer 2009; 10: 118–123.
Google Scholar | Crossref | Medline | ISI29. Galluzzi, L, Senovilla, L, Vitale, I, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31(15): 1869–1883.
Google Scholar | Crossref | Medline30. Nakagawa, K, Yokota, J, Wada, M, et al. Levels of glutathioneS transferase π mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Jpn J Cancer Res 1988; 79(3): 301–304.
Google Scholar | Crossref | Medline31. Stoehlmacher, J, Park, DJ, Zhang, W, et al. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 2004; 91(2): 344–354.
Google Scholar | Crossref | Medline32. Allan, JM, Wild, CP, Rollinson, S, et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci 2001; 98(20): 11592–11597.
Google Scholar | Crossref | Medline33. Pincinato, EC, Costa, EF, Lopes-Aguiar, L, et al. GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation. Sci Rep 2019; 9(1): 1.
Google Scholar | Crossref | Medline34. Ma, J, Zhu, SL, Liu, Y, et al. GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer. Oncotarget 2017 ;8(42): 72939.
Google Scholar | Crossref | Medline35. Kim, HS, Kim, MK, Chung, HH, et al. Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecol Oncol 2009; 113: 264–269.
Google Scholar | Crossref | Medline